D.A. Davidson & Co. Cytom X Therapeutics, Inc. Transaction History

D.A. Davidson & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 05, 2019	SELL	$7.38 - $12.25 $74,021 - $122,867	-10,030 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$9.35 - $11.41 $93,780 - $114,442	10,030 New	10,030 $113,000
Q3 2017 Nov 08, 2017	SELL	$13.53 - $18.17 $33,825 - $45,425	-2,500 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	2,500	2,500 $0

49.4M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $55.4M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.